0001787028-19-000001.txt : 20190905
0001787028-19-000001.hdr.sgml : 20190905
20190904191136
ACCESSION NUMBER: 0001787028-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190905
DATE AS OF CHANGE: 20190904
EFFECTIVENESS DATE: 20190905
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lilly Project Inc.
CENTRAL INDEX KEY: 0001787028
IRS NUMBER: 831808557
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-348025
FILM NUMBER: 191075901
BUSINESS ADDRESS:
STREET 1: 14180 DALLAS PARKWAY, STE 620
CITY: ADDISON
STATE: TX
ZIP: 75002
BUSINESS PHONE: 530-305-7637
MAIL ADDRESS:
STREET 1: 14180 DALLAS PARKWAY, STE 620
CITY: ADDISON
STATE: TX
ZIP: 75002
D
1
primary_doc.xml
X0708
D
LIVE
0001787028
Lilly Project Inc.
14180 DALLAS PARKWAY, STE 620
ADDISON
TX
TEXAS
75002
530-305-7637
DELAWARE
None
None
Corporation
true
2018
James
Kingsley, II
14180 Dallas Parkway, Ste 620
Addison
TX
TEXAS
75002
Executive Officer
Director
Promoter
CEO, President, CFO, Treasurer, Secretary, and Director
Danial
Soleja
14180 Dallas Parkway, Ste 620
Addison
TX
TEXAS
75002
Executive Officer
Director
Promoter
Chief Medical Officer and Director
Other Technology
Decline to Disclose
- 06b
false
2019-08-23
false
true
Convertible Promissory Notes
false
10000
75000
35000
40000
false
1
0
0
0
false
Lilly Project Inc.
James Kingsley, II
James Kingsley, II
CEO
2019-09-04